DNA methylation regulated microRNAs in human cervical cancer

Molecular Carcinogenesis
Vinay K VargheseKapaettu Satyamoorthy

Abstract

Regulation of miRNA gene expression by DNA promoter methylation may represent a key mechanism to drive cervical cancer progression. In order to understand the impact of DNA promoter methylation on miRNAs at various stages of cervical carcinogenesis, we performed DNA methylation microarray on Normal Cervical Epithelium (NCE), Cervical Intraepithelial Neoplasia (CIN I-III) and Squamous Cell Carcinoma (SCC) tissues to identify differentially methylated miRNAs followed by validation by bisulfite sequencing. Further, expression of miRNAs was analyzed by qRT-PCR in clinical tissues and cervical cancer cell lines. Transcriptional activity was determined by luciferase assay. We identified a total of 69 hypermethylated and hypomethylated miRNA promoters encompassing 78 CpG islands in all except Y chromosome, among the three groups. The candidate DNA promoters of miR-424 were significantly hypermethylated and miR-200b and miR-34c were significantly hypomethylated in SCC compared to NCE (P < 0.05). Expression of miR-424, miR-200b, and miR-34c were inversely correlated with promoter DNA methylation in tissue samples. Treatment of cell lines with 5-aza-2'-deoxycytidine showed differential expression in all three miRNAs. We observed a decrea...Continue Reading

References

May 4, 2000·Journal of the National Cancer Institute·H zur Hausen
Jun 26, 2003·Nucleic Acids Research·Paul E BoardmanSimon J Hubbard
Sep 4, 2003·Genome Research·Paul D ThomasApurva Narechania
Dec 20, 2003·Cancer Causes & Control : CCC·Martyn PlummerUNKNOWN IARC Multi-centre Cervical Cancer Study Group
Jun 10, 2005·Nature·Jun LuTodd R Golub
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Aug 4, 2006·Cancer Research·George Adrian Calin, Carlo Maria Croce
Oct 31, 2006·Nature Genetics·Florian EckhardtStephan Beck
Sep 26, 2007·Human Molecular Genetics·Manel Esteller
Jul 31, 2007·Cancer Biology & Therapy·Liangfeng HanSaraswati Sukumar
Sep 26, 2007·Nature Genetics·Michael KerteszEran Segal
Nov 13, 2007·Cancer Cell·Heiko Hermeking
Dec 7, 2007·Cancer Research·Xingyue HeGregory J Hannon
Sep 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Amaia LujambioManel Esteller
Jun 29, 2010·Molecular Cancer·Saskia M WiltingRenske D M Steenbergen
Jul 6, 2010·Methods : a Companion to Methods in Enzymology·Sophia J DochertyJonathan Mill
Jul 28, 2010·Genes, Chromosomes & Cancer·Kuo-Wang TsaiWen-Chang Lin
Nov 26, 2010·Molecular Biology Reports·Yue-Sheng LongWei-Ping Liao
Nov 30, 2010·Human Molecular Genetics·Dvir AranAsaf Hellman
Jan 26, 2011·Medical Oncology·Qunxian RaoZhongqiu Lin
Aug 9, 2011·Nucleic Acids Research·Chia-Hung ChienHsien-Da Huang
Feb 16, 2012·Molecular Systems Biology·Stefan UhlmannOzgür Sahin
May 26, 2012·Cancer Cell·Daniel D De CarvalhoPeter A Jones
Sep 7, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dharanija MadhavanBarbara Burwinkel
Sep 18, 2012·Neuroscience Letters·Jiong GengZhengxiang Yang
Jan 7, 2014·PloS One·LaTanya V WilliamsOlga V Volpert
Jan 29, 2014·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Carlo La Vecchia, Stefania Boccia

❮ Previous
Next ❯

Citations

Jul 6, 2019·Anti-cancer Drugs·Zukile MbitaZodwa Dlamini
Dec 10, 2019·Clinical & Experimental Metastasis·Padacherri Vethil JishnuShama Prasada Kabekkodu
Sep 29, 2020·Cancer Management and Research·Wenmin Zhang, Suping Zhang
Jun 21, 2021·Critical Reviews in Oncology/hematology·Carolina Simão FlausinoFilipe Modolo
Nov 13, 2021·Experimental and Therapeutic Medicine·Adrian AlbulescuAnca Botezatu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.